CD15 Monoclonal Antibody(Q89)

The product of this gene transfers fucose to N-acetyllactosamine polysaccharides to generate fucosylated carbohydrate structures. It catalyzes the synthesis of the non-sialylated antigen, Lewis x (CD15).

The CD15 Monoclonal Antibody (Q89) is a highly specialized and meticulously developed product that serves as an invaluable tool in the field of immunology. This antibody, derived from a hybridoma cell line, exhibits exceptional specificity and sensitivity towards the CD15 antigen, making it an ideal choice for various research applications.

With its superior performance, the CD15 Monoclonal Antibody (Q89) enables precise and accurate detection of CD15 expression in a wide range of biological samples. This antibody has been extensively validated and optimized to ensure consistent and reliable results, allowing researchers to confidently explore the role of CD15 in various physiological and pathological processes.

The CD15 Monoclonal Antibody (Q89) is manufactured using state-of-the-art techniques and adheres to the highest quality standards. Its exceptional purity and low background staining contribute to enhanced signal-to-noise ratios, facilitating the identification and analysis of CD15-positive cells with utmost precision.

Furthermore, the CD15 Monoclonal Antibody (Q89) offers exceptional versatility, as it is compatible with various experimental techniques, including flow cytometry, immunohistochemistry, and immunofluorescence. This versatility allows researchers to employ the antibody in a multitude of experimental setups, expanding the scope of their investigations.

In summary, the CD15 Monoclonal Antibody (Q89) is a meticulously crafted and highly reliable tool that empowers researchers in the field of immunology to delve deeper into the intricacies of CD15 expression. Its exceptional specificity, sensitivity, and versatility make it an indispensable asset for any laboratory seeking to unravel the mysteries of CD15 and its implications in various biological processes.